Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

0.7001
Delayed Data
As of Jan 20
 -0.0641 / -8.39%
Today’s Change
0.51
Today|||52-Week Range
1.59
+10.32%
Year-to-Date
Institutional investors purchased a net $45.4 thousand shares of XTLB during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 7.08% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Other institutional5.82%
Mutual fund holders1.26%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2016SABBY CAPITAL LLC  Sold 27.2 Thousand shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC5.28%724,134459,825-27,155-3.61%
Invesco Asset Management Ltd.0.95%129,81182,43000.00%
Citadel Advisors LLC0.52%70,59144,825+70,591--
IBI Mutual Funds Management (1978...0.29%40,30025,59100.00%
Morgan Stanley & Co. LLC0.02%2,6001,651+2,000+333.33%
U-Bank Mutual Funds Ltd.0.02%2,6151,66100.00%
Tower Research Capital LLC0.00%60038100.00%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.72%98,01362,23800.00%
I.B.I. Foreign Equity Liable0.29%40,30025,59100.00%
Keystone Investment Trust Plc0.19%25,84016,40800.00%
Invesco Perpetual UK 2 Invt. Seri...0.04%5,9583,78300.00%
Modus Menayot Clali0.02%2,6151,66100.00%